Toxicological Centre, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium.
Anal Bioanal Chem. 2018 Dec;410(30):7871-7880. doi: 10.1007/s00216-018-1402-2. Epub 2018 Oct 5.
Organophosphate flame retardants and plasticizers (PFRs) are a group of chemicals widely added to consumer products. PFRs are quickly metabolized in the human body into two types of metabolites, (1) dialkyl and diaryl phosphate esters (DAPs), such as diphenyl phosphate (DPHP) and bis(1,3-dichloro-2-propyl) phosphate (BDCIPP); and (2) hydroxylated PFRs (HO-PFRs), such as 1-hydroxy-2-propyl bis(1-chloro-2-propyl) phosphate (BCIPHIPP) and 2-hydroxyethyl bis(2-butoxyethyl) phosphate (BBOEHEP). Existing analytical methods usually focus on DAPs; therefore, human biomonitoring data on HO-PFRs remain scarce. In this study, an analytical procedure was developed for the simultaneous quantification of multiple PFR metabolites in human urine, covering eight DAPs and six HO-PFRs. Sample preparation was optimized to include all target compounds using Bond-Elut C18 solid-phase extraction cartridges, followed by instrumental analysis based on liquid-chromatography coupled to tandem mass spectrometry (LC-MS/MS). Method performance was validated according to established guidelines and satisfactory results were obtained for all metabolites in terms of recovery, linearity, limits of quantification, precision, and accuracy. Recoveries ranged from 87 to 112%. Method detection limits from 0.002 ng/mL for 2-ethyl-5-hydroxyhexyl diphenyl phosphate (5-HO-EHDPHP) to 0.66 ng/mL for 4-hydroxyphenyl phenyl phosphate (4-HO-DPHP). Seven PFR metabolites were frequently detected in a small biomonitoring study (n = 14), among them bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), di-n-butyl phosphate (DNBP), 5-HO-EHDPHP, and BBOEHEP. Highest mean concentrations were found for DPHP, 2-ethylhexyl phenyl phosphate (EHPHP), and BCIPHIPP, while 4-HO-DPHP, 5-HO-EHDPHP, and EHPHP were detected in urine for the first time. Overall, the obtained results demonstrate that the developed method can be used for the simultaneous determination of 14 urinary biomarkers of exposure to PFRs. Graphical abstract ᅟ.
有机磷阻燃剂和增塑剂 (PFRs) 是一组广泛添加到消费品中的化学物质。PFRs 在人体内迅速代谢为两种类型的代谢物:(1) 二烷基和二芳基磷酸盐 (DAPs),如磷酸二苯酯 (DPHP) 和双(1,3-二氯-2-丙基)磷酸酯 (BDCIPP);和 (2) 羟基化 PFRs (HO-PFRs),如 1-羟基-2-丙基双(1-氯-2-丙基)磷酸酯 (BCIPHIPP) 和 2-羟乙基双(2-丁氧基乙基)磷酸酯 (BBOEHEP)。现有的分析方法通常侧重于 DAPs;因此,人体生物监测数据中关于 HO-PFRs 的数据仍然很少。在这项研究中,开发了一种用于同时定量测定人尿液中多种 PFR 代谢物的分析程序,涵盖了八种 DAPs 和六种 HO-PFRs。通过 Bond-Elut C18 固相萃取小柱优化样品制备,以包含所有目标化合物,随后基于液相色谱-串联质谱 (LC-MS/MS) 进行仪器分析。根据既定准则验证了方法性能,所有代谢物的回收率、线性、定量限、精密度和准确性均获得满意结果。回收率范围为 87%至 112%。方法检测限从 2-乙基-5-羟基己基二苯基磷酸酯 (5-HO-EHDPHP) 的 0.002ng/mL 到 4-羟基二苯基磷酸酯 (4-HO-DPHP) 的 0.66ng/mL。在一项小型生物监测研究 (n=14) 中,经常检测到七种 PFR 代谢物,其中包括双(1,3-二氯-2-丙基)磷酸酯 (BDCIPP)、二正丁基磷酸酯 (DNBP)、5-HO-EHDPHP 和 BBOEHEP。二苯基磷酸酯 (DPHP)、2-乙基己基苯基磷酸酯 (EHPHP) 和 BCIPHIPP 的平均浓度最高,而 4-HO-DPHP、5-HO-EHDPHP 和 EHPHP 则是首次在尿液中检测到。总体而言,所得结果表明,所开发的方法可用于同时测定 14 种有机磷阻燃剂暴露的尿液生物标志物。